Mapping of molecular pathways, biomarkers and drug targets for diabetic nephropathy. - Wikidata - awgldk - TriplyDB

Mapping of molecular pathways, biomarkers and drug targets for diabetic nephropathy.

Mapping of molecular pathways, biomarkers and drug targets for diabetic nephropathy.

http://www.wikidata.org/entity/Q44871811

about

In-silico human genomics with GeneCards Proteomics for prediction of disease progression and response to therapy in diabetic kidney disease Applying MetaMap to Medline for identifying novel associations in a large clinical dataset: a feasibility analysis From molecular signatures to predictive biomarkers: modeling disease pathophysiology and drug mechanism of action.Drug target inference through pathway analysis of genomics data.A panel of novel biomarkers representing different disease pathways improves prediction of renal function decline in type 2 diabetes.Vascular endothelial growth factor A as predictive marker for mTOR inhibition in relapsing high-grade serous ovarian cancer Crucial genes associated with diabetic nephropathy explored by microarray analysis The genetics of diabetic nephropathy.Proteomic biomarkers in kidney disease: issues in development and implementation.Molecular disease presentation in diabetic nephropathy.Body fluid peptide and protein signatures in diabetic kidney diseases.Prognostic clinical and molecular biomarkers of renal disease in type 2 diabetes.Molecular models of the cardiorenal syndrome.Transcriptomics in kidney biopsy is an untapped resource for precision therapy in nephrology: a systematic review.Albuminuria, serum creatinine, and estimated glomerular filtration rate as predictors of cardio-renal outcomes in patients with type 2 diabetes mellitus and kidney disease: a systematic literature review.

P2860

Q21245450-CE4B4D24-A50C-49D5-9C99-9E18814E0B7F Q26747131-217D7169-007D-490B-9D90-142E204DBEA3 Q28656396-D92AC556-AAA8-4017-AD3D-731FC72D455F Q34391213-5493C905-24C0-4412-96C7-F730DD41D044 Q34570294-AD60E475-F694-4A0B-9D4D-BFA103DDA6C9 Q35606905-836E6091-CA82-46B1-AA98-0058B58E9E0E Q35992948-022BB031-AF45-496A-AB42-C7B6871BC402 Q36128998-1EB3CDBA-C195-44D0-B824-5236EB71B71D Q37590421-D1FF4693-688C-401B-9DB7-AFDB90ED5330 Q38341211-1DF3AB30-3985-436B-815F-905ECC6F0C28 Q38460161-91C46C04-A40B-49BE-8491-4E050ED7E74C Q38553924-DE360A75-B399-4F24-8925-B954909A3ACF Q38553932-3E50A43B-4F83-41D6-8211-84DD4A2D3154 Q46899838-23B26DED-1802-484C-B2F3-4C0C4C810901 Q47835456-882FD185-0A76-4F66-8D3D-7B187989E070 Q49199995-AA611F2C-1DD5-4002-BBC3-60C430F352F0

P2860

Mapping of molecular pathways, biomarkers and drug targets for diabetic nephropathy.

http://www.wikidata.org/entity/Q44871811

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

Mapping of molecular pathways, biomarkers and drug targets for diabetic nephropathy.

@en

Mapping of molecular pathways, biomarkers and drug targets for diabetic nephropathy.

@nl

type

label

Mapping of molecular pathways, biomarkers and drug targets for diabetic nephropathy.

@en

Mapping of molecular pathways, biomarkers and drug targets for diabetic nephropathy.

@nl

prefLabel

Mapping of molecular pathways, biomarkers and drug targets for diabetic nephropathy.

@en

Mapping of molecular pathways, biomarkers and drug targets for diabetic nephropathy.

@nl

P1433

Q44871811-D13EA9E8-A7AD-4F40-8CEE-D9FF1EA77EC1

P1476

Q44871811-26EFB58C-7ED7-4EFE-8713-3FE336156B3C

P2093

Q44871811-39382A90-553C-40CC-A9C1-139745A0BBBA

Q44871811-3A7B3FEF-2475-4252-A85F-46889045F12D

Q44871811-487DB4A3-B51B-4646-AE26-61E7DCCBE501

Q44871811-95DF0C09-1B80-4792-AC28-B5122BC472A5

Q44871811-BC3717A1-CCE0-4F73-80BB-23EEEBF553F5

Q44871811-BC8B366A-F9A9-48E1-8CE0-784AC4670C81

Q44871811-C660875F-0A4C-4406-893B-4ECC9492F759

Q44871811-DFE89F05-D67D-4562-9D3D-C3C569BAD66F

Q44871811-E36CF756-9A9D-4EF0-91AB-B27A3CEAF646

Q44871811-F2B47CF0-3153-44DA-87D8-C4B9CBB63262

P2860

Q44871811-0E047489-076D-4B3E-8039-794F072D5774

Q44871811-1196C898-E6B5-4552-BF8D-8059748EAE64

Q44871811-17FE609B-665A-4E7F-8F72-874882D5F351

Q44871811-185E3E47-1F98-4559-94F4-1974295A81AD

Q44871811-26F28575-7400-4332-9873-57E9B902790C

Q44871811-2957CBC8-D84B-4166-8FB2-4F594CF5B5B0

Q44871811-296CE7A1-4E05-4FDD-B458-5D753A1BCAC4

Q44871811-37B554CC-B344-4C18-A08B-39CC24892383

Q44871811-37D1B1F3-4B43-4717-AD55-46E21B6D584E

Q44871811-3CD20199-DF3E-4B8B-8CD4-AB9ADFB43094

P304

Q44871811-1EC9128E-1ABF-4798-82E6-3276715576CC

P31

Q44871811-F145A581-AD91-498D-B073-FC7DDCAF7E90

P356

Q44871811-051A6B43-8B2A-47D9-A119-F40BB174E09E

P433

Q44871811-FAFC3742-90DE-4F0B-B5CE-615B3C18AB01

P478

Q44871811-7EB8752C-718D-4109-8C6B-27E021C5903C

P50

Q44871811-B277A401-5E67-4E11-A4BD-A2A30054573E

P577

Q44871811-F1C48451-1B8F-40D7-9D74-31EB85EEC1B7

P5875

Q44871811-4702D368-6609-4654-9E1B-B6E1EA35EBB7

P698

Q44871811-5A16B716-8A8F-43E9-BD1D-C9055289718F

P356

P1433

Proteomics - Clinical Applications

P1476

Mapping of molecular pathways, biomarkers and drug targets for diabetic nephropathy.

@en

P2093

Andreas Heinzel

http://www.w3.org/2001/XMLSchema#string

Bernd Mayer

http://www.w3.org/2001/XMLSchema#string

Gert Mayer

http://www.w3.org/2001/XMLSchema#string

Gil Stelzer

http://www.w3.org/2001/XMLSchema#string

Johannes Söllner

http://www.w3.org/2001/XMLSchema#string

Konrad Mönks

http://www.w3.org/2001/XMLSchema#string

Paul Perco

http://www.w3.org/2001/XMLSchema#string

Rainer Oberbauer

http://www.w3.org/2001/XMLSchema#string

Raul Fechete

http://www.w3.org/2001/XMLSchema#string

Susanne Eder

http://www.w3.org/2001/XMLSchema#string

P2860

A dynamic network approach for the study of human phenotypes

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

New loci associated with kidney function and chronic kidney disease

DrugBank: a knowledgebase for drugs, drug actions and drug targets

HMDB: a knowledgebase for the human metabolome

The human disease network

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

Expression-based network biology identifies alteration in key regulatory pathways of type 2 diabetes and associated risk/complications

Building disease-specific drug-protein connectivity maps from molecular interaction networks and PubMed abstracts

A guide to the Proteomics Identifications Database proteomics data repository

P304

354-366

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PRCA.201000136

http://www.w3.org/2001/XMLSchema#string

P433

5-6

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-04-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51049936

http://www.w3.org/2001/XMLSchema#string

P698

21491608

http://www.w3.org/2001/XMLSchema#string